| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma. | Mol Cancer Ther | 2013 | 0.94 |
| 2 | Immunogenicity assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine. | Bioanalysis | 2013 | 0.82 |